(July 27, 2020) Research from the Ovarian Cancer Association Consortium (OCAC) found that “using menopausal hormone therapy prior to diagnosis extends ovarian cancer survival.” This was found through a comprehensive … Continued
Find resources and make connections at OCRA’s 2020 National Conference September 29 – October 2, 2020 Early Bird Registration Ends 7/31! We’ll be honest—when we decided to host our annual National … Continued
There’s so much happening at OCRA – from groundbreaking research to advocacy work, patient support to fundraising efforts. Starting this summer, we will share periodic highlights so that you can … Continued
(July 7, 2020) Presented as part of the American Association for Cancer Research (AACR) Virtual Annual Meeting, Dr. Kala Visvanathan and colleagues at Johns Hopkins found that statins “were associated … Continued
Hui Shen, PhD, spoke of a particular moment that helped cement her commitment to ovarian cancer research. She was working on a complicated project that required a new genomics technology to … Continued
(June 24, 2020) Published this month in the International Journal of Cancer, researchers in Australia have found that “A healthy lifestyle after diagnosis, in particular not smoking and being physically … Continued
Recently we announced that OCRA’s 2020 National Conference will take place virtually on September 29-October 2, 2020. We are very excited to bring you an amazing program featuring information on … Continued
Duygu Ozmadenci, PhD, grew up in a small town on the Black Sea region of Turkey, across the waters from Chernobyl. As a teenager, she read a book that told … Continued
(June 11, 2020) Letters of Intent (LOIs) for Ovarian Cancer Research Alliance’s 2021 scientific grant awards are now open for submission. LOIs are due by July 10, 2020. Accepting LOIs … Continued
First-of-its-kind clinical trial validates remote genetic counseling (New York) June 01, 2020 – Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies … Continued
Scared. Overwhelmed. Exhausted. Befuddled. These are common words one might use to describe how we feel during this unprecedented time in history. But Dmitriy Zamarin, MD, PhD, adds “fascinated” to … Continued
(May 4, 2020) On April 29th, the Food and Drug Administration approved niraparib (Zejula, GlaxoSmithKline) as a first-line maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer, … Continued
Get email updates about research news, action alerts, and ways to join the fight.
